Rationale: The discriminative-stimulus effects of cocaine have been reported to be mediated by indirect agonist actions initiated by the blockade of dopamine uptake, and the potencies of drugs that have discriminative-stimulus effects like cocaine are directly related to their dopamine transporter binding affinities. The binding to the dopamine transporter by cocaine and many of its analogs has been reported to fit better using a two-site model than a one-site model. Objectives: The present study examined the relationship among binding affinities of dopamine uptake inhibitors at these two sites and their potencies to produce discriminative-stimulus effects. Methods: The inhibition constants (K i values) were derived for unlabeled dopamine u...
Amphetamine and cocaine, commonly abused psychostimulants, often produce similar physiologic and beh...
The highly selective dopamine D-3 receptor ligand, (+)-PD 128907 4aR10bR-(+)-trans-3,4,4a,10b-tetrah...
The discovery and evaluation of high affinity dopamine transport inhibitors with low abuse liability...
Rationale: Recent data suggest that dopamine (DA) D1-like receptor full agonists may be potential ph...
The dopamine transporter (DAT) is a membrane protein that is responsible for the reuptake of dopamin...
It has been suggested that cocaine and mazindol bind to sep-arate sites on the dopamine transporter....
The rate of entry of drugs into brain is thought to be a factor in their abuse liability. In this in...
Analogs of benztropine (BZT) bind to the dopamine (DA) trans-porter and inhibit DA uptake but often ...
Cocaine exerts its stimulatory effect by inhibiting the dopamine transporter (DAT). However, novel b...
Cocaine, amphetamines and other psychostimulants inhibit synaptic dopamine uptake by interfering wit...
[3H]WIN 35,065–2 binding to striatal membranes was characterized, primarily by centrifugation assay....
AbstractThe experiments reported in this study tested the hypothesis that tight binding dopamine (DA...
Competition kinetic analysis was performed to examine the interaction mechanism of the dopamine tran...
Whereas dopamine reuptake inhibitors substitute for the discriminative stimulus properties of cocain...
Cocaine binds and inhibits dopamine transporter (DAT), norepinephrine transporter (NET) and serotoni...
Amphetamine and cocaine, commonly abused psychostimulants, often produce similar physiologic and beh...
The highly selective dopamine D-3 receptor ligand, (+)-PD 128907 4aR10bR-(+)-trans-3,4,4a,10b-tetrah...
The discovery and evaluation of high affinity dopamine transport inhibitors with low abuse liability...
Rationale: Recent data suggest that dopamine (DA) D1-like receptor full agonists may be potential ph...
The dopamine transporter (DAT) is a membrane protein that is responsible for the reuptake of dopamin...
It has been suggested that cocaine and mazindol bind to sep-arate sites on the dopamine transporter....
The rate of entry of drugs into brain is thought to be a factor in their abuse liability. In this in...
Analogs of benztropine (BZT) bind to the dopamine (DA) trans-porter and inhibit DA uptake but often ...
Cocaine exerts its stimulatory effect by inhibiting the dopamine transporter (DAT). However, novel b...
Cocaine, amphetamines and other psychostimulants inhibit synaptic dopamine uptake by interfering wit...
[3H]WIN 35,065–2 binding to striatal membranes was characterized, primarily by centrifugation assay....
AbstractThe experiments reported in this study tested the hypothesis that tight binding dopamine (DA...
Competition kinetic analysis was performed to examine the interaction mechanism of the dopamine tran...
Whereas dopamine reuptake inhibitors substitute for the discriminative stimulus properties of cocain...
Cocaine binds and inhibits dopamine transporter (DAT), norepinephrine transporter (NET) and serotoni...
Amphetamine and cocaine, commonly abused psychostimulants, often produce similar physiologic and beh...
The highly selective dopamine D-3 receptor ligand, (+)-PD 128907 4aR10bR-(+)-trans-3,4,4a,10b-tetrah...
The discovery and evaluation of high affinity dopamine transport inhibitors with low abuse liability...